{
  "meta": {
    "title": "77_Guillain-Barre_Syndrome_And_Other_Immune-Mediated_Neuropathies",
    "url": "https://brainandscalpel.vercel.app/77-guillain-barre-syndrome-and-other-immune-mediated-neuropathies-1fb42094.html",
    "scrapedAt": "2025-11-30T12:29:05.209Z"
  },
  "questions": [
    {
      "text": "Which of the following is the most common antecedent infectious cause of Guillain-Barre syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Cytomegalovirus"
        },
        {
          "id": 2,
          "text": "Mycoplasma pneumoniae"
        },
        {
          "id": 3,
          "text": "Campylobacter jejuni"
        },
        {
          "id": 4,
          "text": "Epstein Barr virus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><em><strong>Campylobacter jejuni</strong></em>&nbsp;is one of the <strong>most common </strong>risk factors for GBS.</p>\n<p>Infections that may trigger GBS are:</p>\n<ul>\n<li><em>Campylobacter jejuni</em>&nbsp;</li>\n<li>Cytomegalovirus (CMV)</li>\n<li>Epstein Barr virus</li>\n<li>Mycoplasma</li>\n<li>Varicella zoster virus</li>\n<li>Human immunodeficiency virus (HIV), dengue, or influenza, Zika, hepatitis</li>\n</ul>\n<p>Less commonly <strong>vaccinations</strong>, <strong>surgical procedures</strong>, and <strong>trauma</strong> have been reported to trigger the development of GBS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7557",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following autoantibody isotype is involved in the pathogenesis of Guillian-Barre syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "IgA"
        },
        {
          "id": 2,
          "text": "IgG"
        },
        {
          "id": 3,
          "text": "IgM"
        },
        {
          "id": 4,
          "text": "IgE"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>IgG&nbsp;</strong>isotype of autoantibody is involved in the pathogenesis of GBS.</p>\n<p><strong>IgM</strong> isotype autoantibodies are known to play a role in some types of <strong>chronic immune neuropathies</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7559",
      "difficulty": "medium"
    },
    {
      "text": "In Guillain-Barre syndrome due to antecedent infection with Campylobacter jejuni, the autoantibodies are most commonly directed against which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "GM1"
        },
        {
          "id": 2,
          "text": "GD1a"
        },
        {
          "id": 3,
          "text": "GD1b"
        },
        {
          "id": 4,
          "text": "GalNac-GD1a"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Autoantibodies</strong> in GBS due to <em><strong>Campylobacter jejuni</strong></em> infection are directed most commonly against <strong>GM1 gangliosidase.</strong></p><hr><h3>Related Pearl: Mechanism of Immunopathogenesis of Guillain-Barre Syndrome</h3><p>The following sequence of events, takes into consideration, the development of Guillain-Barre syndrome (GBS) associated with <em>Campylobacter jejuni</em><strong> infection</strong>.</p>\n<ol>\n<li><strong>B cells</strong> recognize glycoconjugates on <strong> jejuni (Cj)</strong> that cross-react with <strong>ganglioside</strong> present on <strong>Schwann cell surface</strong> and <strong>subjacent peripheral nerve myelin</strong>.</li>\n<li>Most of the B cells are activated via a partially T cell&ndash;dependent route and secrete primarily <strong>IgG autoantibodies</strong>. Some B cells, activated via a T cell&ndash;independent mechanism, secrete primarily IgM</li>\n<li><strong>The</strong> <strong>activated B cells</strong> escape from Peyer&rsquo;s patches into regional lymph nodes.</li>\n<li><strong>Activated T cells</strong> also function to assist in the opening of the blood-nerve barrier, facilitating penetration of pathogenic autoantibodies.</li>\n<li>The earliest changes in myelin consist of <strong>edema between myelin lamellae</strong> and <strong>vesicular disruption</strong> of the outermost myelin layers.</li>\n<li>These effects are associated with activation of the <strong>C5b-C9 membrane attack complex</strong> and mediated by <strong>calcium entry</strong>; it is possible that the macrophage cytokine tumor necrosis factor (TNF) also participates in <strong>myelin damage</strong>.</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b40cb513616a452c90a928eb9e4fc6d7x1280x1987.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Antibodies seen in Guillian Barre syndrome</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Antibody</strong></td>\n</tr>\n<tr>\n<td>AIDP</td>\n<td>Anti GM1</td>\n</tr>\n<tr>\n<td>AMAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>AMSAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>Miller Fisher syndrome</td>\n<td>Anti GQ1b</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>AIDP-Acute inflammatory demyelinating polyneuropathy&nbsp;</li>\n<li>AMAN-Acute motor axonal neuropathy&nbsp;</li>\n<li>AMSAN-Acute motor sensory axonal neuropathy&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7563",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most common type of Guillian-Barre syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Acute motor axonal neuropathy"
        },
        {
          "id": 2,
          "text": "Acute inflammatory demyelinating polyneuropathy"
        },
        {
          "id": 3,
          "text": "Acute motor sensory axonal neuropathy"
        },
        {
          "id": 4,
          "text": "Miller Fisher syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Acute inflammatory demyelinating</strong> <strong>polyneuropathy (AIDP)</strong> is the most common type of GBS.</p>\n<p>There are several <strong>types of Guillain&ndash;Barre syndrome,</strong> which are recognized by electrodiagnostic studies and pathological distinctions. These include:</p>\n<p>A. Demyelinating</p>\n<ul>\n<li><strong>Acute inflammatory demyelinating polyneuropathy</strong> (AIDP) - most common</li>\n</ul>\n<p>B. Axonal</p>\n<ul>\n<li><strong>Acute motor axonal neuropathy</strong> (AMAN)</li>\n<li><strong>Acute motor&ndash;sensory axonal neuropathy</strong> (AMSAN)</li>\n</ul>\n<p>C. Regional GBS syndromes</p>\n<ul>\n<li><strong>Miller&ndash;Fisher syndrome</strong> (MFS)</li>\n<li>Pure sensory forms</li>\n<li>Ophthalmoplegia with anti-GQ1b antibodies as part of severe motor-sensory GBS</li>\n<li>GBS with severe bulbar and facial paralysis</li>\n<li>Acute pandysautonomia</li>\n</ul><hr><h3>Related Pearl: Antibodies seen in Guillian Barre syndrome</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Antibody</strong></td>\n</tr>\n<tr>\n<td>AIDP</td>\n<td>Anti GM1</td>\n</tr>\n<tr>\n<td>AMAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>AMSAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>Miller Fisher syndrome</td>\n<td>Anti GQ1b</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>AIDP-Acute inflammatory demyelinating polyneuropathy&nbsp;</li>\n<li>AMAN-Acute motor axonal neuropathy&nbsp;</li>\n<li>AMSAN-Acute motor sensory axonal neuropathy&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7556",
      "difficulty": "easy"
    },
    {
      "text": "Which type of Guillain-Barre syndrome most commonly affects patients in the pediatric age group?",
      "choices": [
        {
          "id": 1,
          "text": "Acute motor axonal neuropathy"
        },
        {
          "id": 2,
          "text": "Acute inflammatory demyelinating polyneuropathy"
        },
        {
          "id": 3,
          "text": "Acute motor sensory axonal neuropathy"
        },
        {
          "id": 4,
          "text": "Miller Fisher syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>acute motor axonal neuropathy (AMAN)</strong> subtype of Guillain-Barre syndrome (GBS) is more common in <strong>pediatric age groups</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Age group affected</strong></td>\n</tr>\n<tr>\n<td>Acute inflammatory demyelinating polyneuropathy (AIDP)</td>\n<td>Adults </td>\n</tr>\n<tr>\n<td>Acute motor axonal neuropathy (AMAN)</td>\n<td>\n<p>Children</p>\n<p>Young adults</p>\n</td>\n</tr>\n<tr>\n<td>Acute motor-sensory axonal neuropathy (AMSAN)</td>\n<td>Mostly adults</td>\n</tr>\n<tr>\n<td>Miller–Fisher syndrome</td>\n<td>\n<p>Adults </p>\n<p>Children</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7564",
      "difficulty": "medium"
    },
    {
      "text": "Acute inflammatory demyelinating polyneuropathy differs from acute motor axonal neuropathy, in that, in the latter, the complement deposition along with IgG antibodies occurs at:",
      "choices": [
        {
          "id": 1,
          "text": "Nodes of Ranvier"
        },
        {
          "id": 2,
          "text": "Neuromuscular junction"
        },
        {
          "id": 3,
          "text": "Oligodendrocytes"
        },
        {
          "id": 4,
          "text": "Schwann cells"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In <strong>AMAN,</strong> the complement along with IgG is deposited at the <strong>nodes of Ranvier</strong> of <strong>large motor axons.</strong></p>\n<p>In <strong>AIDP,</strong> complement deposits along the outer surface of the <strong>Schwann cell.</strong> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7567",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following features would you not expect to see in a patient with Guillian-Barre syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Absent reflexes in lower limb"
        },
        {
          "id": 2,
          "text": "Ascending paralysis"
        },
        {
          "id": 3,
          "text": "Early bladder dysfunction"
        },
        {
          "id": 4,
          "text": "Bulbar paralysis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Bladder dysfunction is not usually severe and does not appear early in the course of <strong>Guillain-Barre Syndrome(GBS)</strong>. If bladder dysfunction is a prominent feature and comes early in the course, diagnostic possibilities other than GBS should be considered.</p>\n<p>GBS is an acute demyelinating polyradiculoneuropathy. It is an autoimmune disorder triggered by infections like:</p>\n<ul>\n<li><em>Campylobacter jejuni&nbsp;</em></li>\n<li>Cytomegalovirus (CMV)</li>\n<li>Epstein Barr virus</li>\n<li>Mycoplasma</li>\n<li>Varicella zoster virus</li>\n<li>Human immunodeficiency virus (HIV), dengue, or influenza</li>\n</ul>\n<p>It manifests as a rapidly evolving <strong>areflexic motor paralysis</strong>, with or without sensory disturbance. The usual pattern is&nbsp;<strong>ascending paralysis</strong>. Proximal and distal muscles are equally involved. The lower cranial nerves are frequently affected, causing <strong>bulbar weakness</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7552",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following sensory deficits is severely affected in a patient with Guillain-Barre syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Pain"
        },
        {
          "id": 2,
          "text": "Temperature"
        },
        {
          "id": 3,
          "text": "Proprioception"
        },
        {
          "id": 4,
          "text": "Touch"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Loss</strong> of<strong> proprioception</strong> is <strong>severe</strong> in&nbsp;Guillain-Barre syndrome <strong>(GBS).</strong></p>\n<p>GBS affects the large sensory fibers, leading to attenuation or loss of deep tendon reflexes and loss of proprioception.</p>\n<p>Cutaneous sensory deficits (e.g., loss of pain and temperature sensation) are usually relatively mild.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7554",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents with complaints of lower extremity weakness. He initially noticed difficulty climbing the stairs and now he is unable to stand. He gives a history of bloody diarrhea a few weeks ago. Which of the following parameters are expected to be elevated in the CSF of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Lymphocytes"
        },
        {
          "id": 2,
          "text": "Neutrophils"
        },
        {
          "id": 3,
          "text": "Opening pressure"
        },
        {
          "id": 4,
          "text": "Proteins"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario is suggestive of&nbsp;<strong>Guillain-Barre syndrome (GBS).&nbsp;</strong><strong>Protein </strong>levels are <strong>elevated</strong> (100-1000mg/dl) in the <strong>CSF</strong> of a patient with this condition.</p>\n<p>The CSF cell counts are usually normal. <strong>Albuminocytologic dissociation</strong>, which is an elevation in CSF protein without an elevation in white blood cells, is characteristic in GBS.</p>\n<p>Causes of&nbsp;albuminocytologic dissociation are:</p>\n<ul>\n<li>Guillain-Barre Syndrome</li>\n<li>Spinal cord&nbsp;tumours</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7568",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following conditions does not present with autonomic dysfunction?",
      "choices": [
        {
          "id": 1,
          "text": "Amyloidosis"
        },
        {
          "id": 2,
          "text": "Guillain-Barré syndrome"
        },
        {
          "id": 3,
          "text": "Botulism"
        },
        {
          "id": 4,
          "text": "Subclavian steal syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Subclavian steal syndrome does not present with autonomic dysfunction.</p>\n<p>Option A: <strong>Polyneuropathy</strong> is seen in sporadic and familial amyloidosis. In some cases, <strong>autonomic insufficiency</strong> presents before&nbsp;distal painful polyneuropathy accompanied by sensory loss</p>\n<p>Option B:&nbsp;<strong>Guillain-Barr&eacute;</strong> syndrome is associated with autonomic instability. This can present with <strong>BP fluctuations</strong>, <strong>arrhythmias,</strong> and GI disturbances.</p>\n<p>Option C: Botulinum toxin binds&nbsp;presynaptically to cholinergic nerve terminals. After uptake into the cytoplasm, it&nbsp;<strong>blocks ACh</strong> <strong>release</strong>. Thus, patients with <strong>botulism</strong> present with motor paralysis and <strong>autonomic disturbances.</strong></p><hr><h3>Related Pearl: Neuropathies associated with prominent autonomic dysfunction</h3><div class=\"page\" title=\"Page 3593\">\n<ul>\n<li>Hereditary sensory and autonomic neuropathy</li>\n<li>Amyloidosis (familial and acquired)</li>\n<li>Diabetes mellitus</li>\n<li>Idiopathic pandysautonomia (may be a variant of Guillain-Barré syndrome)</li>\n<li>Porphyria</li>\n<li>HIV-related autonomic neuropathy</li>\n<li>Vincristine and other chemotherapeutic agents</li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7427",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old patient presents with rapidly progressing symmetric ascending paralysis since 2 days. Nerve conduction studies are consistent with demyelination. He is found to have an elevated protein level in his CSF. Which of the following autonomic disturbance is likely to be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Postural hypotension"
        },
        {
          "id": 2,
          "text": "Urinary incontinence"
        },
        {
          "id": 3,
          "text": "Diarrhea"
        },
        {
          "id": 4,
          "text": "Increased sweating"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given scenario is suggestive of&nbsp;<strong>Guillian-Barre syndrome</strong> (GBS).&nbsp;<strong>Postural hypotension</strong> is a common autonomic disturbance seen in this condition.</p>\n<p>Autonomic involvement is common and may occur even in patients whose GBS is otherwise mild.</p>\n<p>The usual autonomic manifestations are:</p>\n<ul>\n<li>Loss of vasomotor control with wide fluctuation in blood pressure, postural&nbsp;hypotension</li>\n<li>Cardiac dysrhythmias</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2093",
      "difficulty": "medium"
    },
    {
      "text": "The triad of Miller-Fisher syndrome includes all of the following, except:",
      "choices": [
        {
          "id": 1,
          "text": "Ataxia"
        },
        {
          "id": 2,
          "text": "Weakness"
        },
        {
          "id": 3,
          "text": "Areflexia"
        },
        {
          "id": 4,
          "text": "Ophthalmoplegia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Weakness is not seen in the triad of <strong>Miller-Fisher syndrome</strong> (MFS).</p><p>Miller Fisher syndrome&nbsp;is a variant of Guillain-Barr&eacute;&nbsp;syndrome(GBS). Like Guillain-Barr&eacute; syndrome, symptoms may be preceded by a viral illness. It classically presents as a triad of:</p>\n<ul>\n<li>Ataxia</li>\n<li>Areflexia</li>\n<li>Ophthalmoplegia</li>\n</ul>\n<p>The condition is usually not associated with weakness, and even if present, is very mild. It is strongly associated with antibodies to the ganglioside GQ1b.</p>\n<p>The prognosis in Miller Fisher syndrome is usually good with recovery beginning within 2 to 4 weeks of the symptom onset, and completing by 6 months. Some individuals are left with residual deficits. Relapses are rare.</p>\n<p>Treatment for Miller Fisher syndrome is identical to treatment for Guillain-Barr&eacute; syndrome: intravenous immunoglobulin (IVIg) or plasmapheresis and supportive care.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7566",
      "difficulty": "easy"
    },
    {
      "text": "A patient presented to the ER with tingling, numbness, and weakness in all four limbs.  She says that the weakness started in the lower limbs and progressed to the upper limbs within a day. History is significant for a recent COVID-19 infection and surgery for cervical spondylosis and disc herniation 3 years ago. CT brain was normal and an MRI of the lumbar spine showed foraminal narrowing at L2-L3. CSF analysis showed increased protein levels. Which of the following is recommended for the initial therapy of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Intrathecal steroids"
        },
        {
          "id": 2,
          "text": "Remdesivir"
        },
        {
          "id": 3,
          "text": "IV Immunoglobulin"
        },
        {
          "id": 4,
          "text": "Plasmapheresis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of&nbsp;<strong>Guillain-Barre syndrome</strong>(GBS) probably as a result of COVID-19.&nbsp;<strong>IV Immunoglobulin</strong>&nbsp;is the recommended<strong> initial therapy</strong> for patients with GBS.&nbsp;</p><p>High-dose intravenous immune globulin (IVIg) and&nbsp;plasmapheresis are both equally effective in GBS and can be used as the initial therapy. However, IVIg is often the initial therapy chosen because of its ease of administration and good safety record. It is administered as <strong>five daily infusions</strong> for a total dose of <strong>2 g/kg</strong> body weight.&nbsp;Glucocorticoids have not been found to be effective in GBS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7570",
      "difficulty": "easy"
    },
    {
      "text": "In a patient with Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy is suspected when _______",
      "choices": [
        {
          "id": 1,
          "text": "GBS deteriorates >5 weeks after onset or relapses at least three times"
        },
        {
          "id": 2,
          "text": "GBS deteriorates >5 weeks after onset or relapses at least two times"
        },
        {
          "id": 3,
          "text": "GBS deteriorates >9 weeks after onset or relapses at least three times"
        },
        {
          "id": 4,
          "text": "GBS deteriorates >8 weeks after onset or relapses at least two times"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Chronic inflammatory demyelinating polyneuropathy<strong> (CIDP) </strong>should be suspected when <strong>GBS</strong> deteriorates <strong>&gt;9 weeks</strong> after onset or <strong>relapses</strong> at <strong>least three times.</strong></p>\n<p>Onset is usually gradual over a few months or longer, but in a few cases, the initial attack is indistinguishable from that of GBS.</p>\n<p><strong>CIDP</strong> is distinguished from GBS by its chronic course. In other respects, this neuropathy shares many features with the common demyelinating form of GBS, including <strong>elevated CSF protein levels </strong>and the electrodiagnostic studies findings of <strong>acquired demyelination.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7571",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions are not associated with chronic inflammatory demyelinating polyneuropathy?",
      "choices": [
        {
          "id": 1,
          "text": "Diabetic mellitus"
        },
        {
          "id": 2,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 3,
          "text": "Lymphoma"
        },
        {
          "id": 4,
          "text": "Hepatitis A  infection"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hepatitis A infection is not associated with CIDP.</p>\n<p>Diseases associated with CIDP are:</p>\n<ul>\n<li>Hepatitis B</li>\n<li>Hepatitis C</li>\n<li>Lymphoma&nbsp;</li>\n<li>HIV</li>\n<li>Diabetic mellitus</li>\n<li>Systemic lupus erythematosus (SLE)</li>\n<li>Pregnancy&nbsp;</li>\n<li>Paraneoplastic syndrome&nbsp;</li>\n<li>Inflammatory bowel disease</li>\n<li>Amyloidosis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2138",
      "difficulty": "medium"
    },
    {
      "text": "All are true about chronic inflammatory demyelinating polyneuropathy, except:",
      "choices": [
        {
          "id": 1,
          "text": "Symptoms present for  > 8 weeks duration"
        },
        {
          "id": 2,
          "text": "Relapse at least 3 times in a patient with Guillain-Barré syndrome"
        },
        {
          "id": 3,
          "text": "Symmetrical weakness"
        },
        {
          "id": 4,
          "text": "Small nerve fibers are affected more than large fibers"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Large nerve fibers</strong> are <strong>affected more</strong> than small fibers in <strong>CIDP.</strong></p>\n<p>Difference between CIDP and Guillain-barré syndrome(GBS):</p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>GBS</strong></td>\n<td><strong>CIDP</strong></td>\n</tr>\n<tr>\n<td>Duration </td>\n<td>&lt;4 weeks</td>\n<td>&gt;8 weeks</td>\n</tr>\n<tr>\n<td>Motor symptoms</td>\n<td>Affected</td>\n<td>Affected</td>\n</tr>\n<tr>\n<td>Sensory symptoms</td>\n<td>Mild </td>\n<td>\n<p>More significant</p>\n<p>Largefiber &gt; small fiber</p>\n</td>\n</tr>\n<tr>\n<td>Autonomic nervous system</td>\n<td>Affected </td>\n<td>Rare</td>\n</tr>\n<tr>\n<td>Antecedent event</td>\n<td>Present</td>\n<td>Rare</td>\n</tr>\n<tr>\n<td>Deep tendon reflex</td>\n<td>Absent </td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Steroid</td>\n<td>No role</td>\n<td>2nd line of treatment</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2137",
      "difficulty": "medium"
    },
    {
      "text": "A patient with chronic inflammatory demyelinating polyneuropathy is undergoing nerve conduction study. Which of the following findings is least likely to be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Low amplitude"
        },
        {
          "id": 2,
          "text": "Decreased conduction velocity"
        },
        {
          "id": 3,
          "text": "Increased distal latency"
        },
        {
          "id": 4,
          "text": "Conduction block"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In CIDP, the<strong> amplitude</strong> is <strong>normal</strong> since the axons are intact.</p>\n<p>Nerve conduction study (NCS) in axonal injury and demyelinating diseases:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Axonal injury&nbsp;</strong></td>\n<td><strong>Demyelination&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Amplitude</td>\n<td>Decreased&nbsp;</td>\n<td>Normal&nbsp;</td>\n</tr>\n<tr>\n<td>Distal latency&nbsp;</td>\n<td>Normal</td>\n<td>Prolonged&nbsp;</td>\n</tr>\n<tr>\n<td>Conduction velocity&nbsp;</td>\n<td>Normal&nbsp;</td>\n<td>Slow&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Conduction block&nbsp;</td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Temporal dispersion&nbsp;</td>\n<td>Absent</td>\n<td>Present&nbsp;</td>\n</tr>\n<tr>\n<td>H wave</td>\n<td>Normal or absent</td>\n<td>Prolonged or absent</td>\n</tr>\n<tr>\n<td>F wave</td>\n<td>Normal or absent</td>\n<td>Prolonged or absent</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2168",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following situations is nerve biopsy not indicated in patients with chronic inflammatory demyelinating polyneuropathy?",
      "choices": [
        {
          "id": 1,
          "text": "When the diagnosis not clear"
        },
        {
          "id": 2,
          "text": "When other causes of polyneuropathy cannot be ruled out"
        },
        {
          "id": 3,
          "text": "When electromyography shows axonal involvement"
        },
        {
          "id": 4,
          "text": "When there is no clinical or electrophysiological evidence of nerve functionality"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Nerve biopsy should not be done if there is no clinical or electrophysiological evidence of nerve functionality of that nerve in <strong>CIDP</strong> patients. This is because&nbsp;completely degenerated nerves usually convey limited information.</p>\n<p>In CIDP, <strong>nerve biopsy</strong> is indicated when:</p>\n<ul>\n<li>Diagnosis is not clear</li>\n<li>Other causes of polyneuropathy cannot be ruled out</li>\n<li>Electromyography (EMG) shows axonal involvement</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2399",
      "difficulty": "medium"
    },
    {
      "text": "All of the following can be used for the treatment of a patient with chronic inflammatory demyelinating polyneuropathy, except:",
      "choices": [
        {
          "id": 1,
          "text": "IV Immunoglobulin"
        },
        {
          "id": 2,
          "text": "Plasmapheresis"
        },
        {
          "id": 3,
          "text": "NSAIDs"
        },
        {
          "id": 4,
          "text": "Glucocorticoids"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>NSAIDs are not used in the treatment of CIDP.</p>\n<p>The treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) includes <strong>high-dose IV immunoglobulin</strong>,<strong>&nbsp;plasmapheresis, </strong>and<strong> glucocorticoids.</strong></p>\n<p>Initial therapy is usually with IV immunoglobulin. If all the first-line agents fail, immunosuppressants are attempted either alone or as an adjunctive treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7573",
      "difficulty": "medium"
    },
    {
      "text": "A 63-year-old man presented with complaints of fatiguability and chronic back pain. On evaluation, he was found to have anemia and hypercalcemia. The X-ray of his skull is given below. Which of the following statements is true with regard to neuropathy seen in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Polyneuropathy is seen in 50% of patients presenting with osteoporotic bone lesions"
        },
        {
          "id": 2,
          "text": "Polyneuropathy is seen in 5% of patients presenting with osteosclerotic features"
        },
        {
          "id": 3,
          "text": "The pattern is sensorimotor"
        },
        {
          "id": 4,
          "text": "Treatment may reverse severe neuropathy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of <strong>multiple myeloma</strong> and the pattern of&nbsp;<strong>polyneuropathy</strong>&nbsp;seen in this condition is&nbsp;<strong>sensorimotor&nbsp;type.</strong></p>\n<p>Multiple myeloma-associated polyneuropathies occur in&nbsp;~5% of patients&nbsp;with the&nbsp;commonly encountered type of multiple myeloma.</p>\n<p>Myeloma with osteosclerotic features, although representing&nbsp;only 3% of all myelomas, is associated with&nbsp;polyneuropathy&nbsp;in one-half of cases.&nbsp;</p>\n<p>Polyneuropathy&nbsp;generally&nbsp;does not reverse&nbsp;even&nbsp;with successful suppression of the&nbsp;myeloma.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c636aac01984449e93116cc7a831604b.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7576",
      "difficulty": "hard"
    },
    {
      "text": "What is the most common pattern of peripheral neuropathy in patients with polyarteritis nodosa?",
      "choices": [
        {
          "id": 1,
          "text": "Pure motor neuropathy"
        },
        {
          "id": 2,
          "text": "Pure sensory neuropathy"
        },
        {
          "id": 3,
          "text": "Symmetric motor-sensory neuropathy"
        },
        {
          "id": 4,
          "text": "Mononeuropathy multiplex"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Most common pattern of peripheral neuropathy in <strong>polyarteritis nodosa</strong> (PAN) is <strong>mononeuritis multiplex</strong> (multifocal motor-sensory neuropathy). It is asymmetric, due to ischemic lesions of nerve trunks and roots.</p>\n<p>Some cases present as a distal, symmetric sensorimotor polyneuropathy. Small- to medium-sized arteries of the vasa nervorum, particularly the epineural vessels, are affected in PAN, resulting in a widespread ischemic neuropathy.</p>\n<p>Combination therapy with <strong>glucocorticoids</strong> and <strong>rituximab</strong> is increasingly recommended as the standard initial treatment, particularly for ANCA-associated vasculitis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7579",
      "difficulty": "medium"
    }
  ]
}